Cargando…
Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation
Hereditary transthyretin amyloidosis (ATTR) is an autosomal dominant disease characterized by the extracellular deposition of the transport protein transthyretin (TTR) as amyloid fibrils. Despite the progress achieved in recent years, understanding why different TTR residue substitutions lead to dif...
Autores principales: | Esperante, Sebastián A., Varejāo, Nathalia, Pinheiro, Francisca, Sant'Anna, Ricardo, Luque-Ortega, Juan Román, Alfonso, Carlos, Sora, Valentina, Papaleo, Elena, Rivas, Germán, Reverter, David, Ventura, Salvador |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406001/ https://www.ncbi.nlm.nih.gov/pubmed/34343569 http://dx.doi.org/10.1016/j.jbc.2021.101039 |
Ejemplares similares
-
The Importance of a Gatekeeper Residue on the Aggregation of Transthyretin: IMPLICATIONS FOR TRANSTHYRETIN-RELATED AMYLOIDOSES
por: Sant'Anna, Ricardo, et al.
Publicado: (2014) -
Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation
por: Sant’Anna, Ricardo, et al.
Publicado: (2017) -
EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023) -
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant'Anna, Ricardo, et al.
Publicado: (2016) -
Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant’Anna, Ricardo, et al.
Publicado: (2023)